BIOSCIENCE MANAGERS: This biotech focused fund explains why it invested $15m in these 2 ASX stocks

Link to Full Article MoneyTalks is Stockhead’s regular recap of the ASX stocks and sectors that fund managers and analysts are looking at right now. Today we hear from BioScience Managers’ managing partner Dr Graham Crooke. BioScience Managers is an Australian life sciences investor established in 2003 and has a solid investment record making over 200 investments across […]

Acrux (ASX:ACR) receives $15M in applications for $2M SPP

Link to Full Article Acrux (ACR) has wrapped up a share purchase plan that was more than seven times oversubscribed after receiving approximately $15.1 million in applications The placement has since been scaled back to roughly $9.9 million, but still marks a significant increase on the $2 million it was initially seeking ACR says funds […]

Acrux receives FDA approval for its generic testosterone topical solution

Link to Full Article Melbourne, Australia; 12 January 2021: Acrux Limited (ASX:ACR) (‘Acrux’ or the ‘Company’) is pleased to announce that the US Food and Drug Administration (‘FDA’) has approved its generic product based on Perrigo’s Testosterone Topical Solution, 30mg/1.5mL. In August 2018, Acrux submitted an Abbreviated New Drug Application (‘ANDA’) to seek approval from […]

Acrux (ASX:ACR) pushes ahead with $2M SPP

Link to Full Article Acrux (ACR) is pushing ahead with its planned share purchase plan (SPP) by sending off a booklet to eligible shareholders. The pharmaceutical company first flagged plans to carry out a fundraise back in late-December, when it successfully netted $7.8 million via a placement. ACR is now hoping to raise an additional $2 […]